IPP Bureau
Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences
By IPP Bureau - January 10, 2023
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Moderna announces advances across mRNA pipeline
By IPP Bureau - January 10, 2023
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
GenNext Technologies appoints Dr. John Grant to its Board of Directors
By IPP Bureau - January 10, 2023
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Zydus receives final approval from the USFDA for Febuxostat Tablets
By IPP Bureau - January 10, 2023
Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).
Lupin receives approval from USFDA for Prasugrel Tablets, USP
By IPP Bureau - January 10, 2023
ProBioGen collaborates with Boehringer Ingelheim on DirectedLuck transposase technology
By IPP Bureau - January 10, 2023
The new project further expands the partner's long-term collaboration on new technologies for R&D
Suburban Diagnostics unveils Reference Laboratory in Mumbai
By IPP Bureau - January 09, 2023
The lab is also the first private lab in West India to have built its Mycobacteriology, Mycology, and Molecular Biology departments within a separate Bio Safety Level - 3 (BSL3) bio-containment lab
Dr. Mandaviya inaugurates Annex Building of ICMR-RMRC, Bhubaneswar
By IPP Bureau - January 09, 2023
The centre has initiated next generation sequencing (NGS) as a tool for undertaking studies on genomic epidemiology of pathogens
All AIIMS can transform into institutes of global excellence: Dr. Mandaviya
By IPP Bureau - January 09, 2023
He urged the dignitaries to collaboratively work on the identified domains of improvement and make detailed reports on them
AIIMS Bhubaneswar provides quality healthcare service in Eastern India: Dr Mandaviya
By IPP Bureau - January 09, 2023
Dr. Mandaviya and Dharmendra Pradhan dedicate Burns Centre at AIIMS; Lays foundation stone of Critical Care Hospital Building, and award 40 gold medals to meritorious students
Protein found in Zebrafish can regenerate aged discs in human vertebrae
By IPP Bureau - January 09, 2023
A study by Agharkar Research Institute (ARI), Pune, has discovered that a protein secreted from intervertebral disc cells induces disc regeneration in aged degenerated discs
KIMS invests further in Sarvejana Healthcare
By IPP Bureau - January 07, 2023
The company now holds 56.61% of the total paid-up equity share capital of Sarvejana Healthcare
Lupin receives approval from USFDA for Fesoterodine Fumarate Extended-Release Tablets
By IPP Bureau - January 07, 2023
Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, (RLD Toviaz®) had estimated annual sales of USD 177 million in the U.S. (IQVIA MAT September 2022).
Dabur India expects low to mid-single digit revenue growth for Q3 FY23
By IPP Bureau - January 07, 2023
International Business is expected to post double-digit revenue growth during the quarter in constant currency.
Zydus launches Topiramate Extended-Release Capsules
By IPP Bureau - January 07, 2023
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the United States.
